Acquired hemophilia A
Clinical trials for Acquired hemophilia A explained in plain language.
Never miss a new study
Get alerted when new Acquired hemophilia A trials appear
Sign up with your email to follow new studies for Acquired hemophilia A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study monitors OBIZUR's safety in rare bleeding disorder
Disease control Recruiting nowThis study is checking how safe OBIZUR is for adults with acquired hemophilia A, a rare condition that causes sudden and severe bleeding. Researchers will look at medical records and track side effects in about 9 people. The goal is to see how well the drug controls bleeding in e…
Matched conditions: ACQUIRED HEMOPHILIA A
Sponsor: Takeda • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug OBIZER monitored in rare bleeding disorder study
Disease control Recruiting nowThis study tracks 25 people in Japan with acquired hemophilia A who receive the drug OBIZER to control bleeding. Researchers will watch for side effects and check if the drug helps stop bleeding episodes. The study does not change how doctors treat patients—it simply collects rea…
Matched conditions: ACQUIRED HEMOPHILIA A
Sponsor: Takeda • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC